Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Antengene Granted IND Approval in China for the Phase Ib Study of ATG-008 (Onatasertib) in Combination with ATG-010 (Selinexor) in Patients with Diffuse Large B-Cell Lymphoma
2021-11-02 08:30
Carcell Biopharma closes an oversubscribed financing round led by Hyfinity Investments
2021-11-02 08:00
Microalgae Milk Pioneer Sophie's Bionutrients Moves to Europe's Alt-protein Hotspot
2021-11-01 16:29
WuXi Biologics Launches a New GMP Commercial Drug Product Facility
2021-11-01 10:19
Antengene Receives FDA Approval of IND for Phase 1 Trial of ATG-101 (PD-L1/4-1BB bispecific antibody) in Solid Tumors and Non-Hodgkin Lymphoma
2021-11-01 08:40
Invetech Named Victorian Top Exporter of the Year
2021-10-30 05:35
Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia
2021-10-29 19:15
Operating Income of Yiling Pharmaceutical in First 3 Quarters Reaches CNY 8.112 Billion, Up 25.81%
2021-10-29 17:17
Over Half of ASEAN Food & Agriculture Policymakers Note Climate Change as the Top Challenge Facing Regional Food Systems
2021-10-29 17:02
3M Health Care and Thermo Fisher Scientific Collaborate to Increase Process Efficiency and Scalability in Commercial Therapeutic Manufacturing
2021-10-29 15:45
Appendix 4C - Q1 FY22 Quarterly Cash Flow Report
2021-10-29 14:50
/DISREGARD RELEASE: Frontier Biotechnologies/
2021-10-29 13:34
EZZ Marks Transition to Genomic Health Following Exceptional FY21 Performance
2021-10-29 04:05
Aiming for Global CDMO, Xcell Therapeutics opens an export route to 62 countries with cell therapy culture technology.
2021-10-28 21:00
Merck Drives New Innovation & Adds Capacity to Advance Next Generation Antibody-drug Conjugate (ADC) Therapies
2021-10-28 21:00
HanAll Biopharma Reports Third Quarter 2021 Results
2021-10-28 21:00
BioVaxys Further Expands Intellectual Property Portfolio in Global Markets
2021-10-28 20:00
Interim report for Q3 2021 : Bactiguard Holding AB (publ)
2021-10-28 15:23
WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility
2021-10-28 08:30
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), In A Two Drug Regimen, Proves Safe And Effective For Critically Ill Hospitalized AIDS Patients
2021-10-27 22:08
1
213
214
215
216
217
452